Richard Pzena’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$310K Buy
+409
New +$309K ﹤0.01% 152
2022
Q4
– Sell
-794
Closed -$547K – 190
2022
Q3
$547K Sell
794
-325
-29% -$205K ﹤0.01% 149
2022
Q2
$661K Buy
1,119
+195
+21% +$127K ﹤0.01% 135
2022
Q1
$645K Buy
924
+20
+2% +$12.7K ﹤0.01% 145
2021
Q4
$571K Sell
904
-73
-7% -$44.9K ﹤0.01% 149
2021
Q3
$591K Sell
977
-137
-12% -$85.1K ﹤0.01% 143
2021
Q2
$622K Sell
1,114
-141
-11% -$71.4K ﹤0.01% 139
2021
Q1
$594K Buy
+1,255
New +$611K ﹤0.01% 153

Other funds holding REGN

Richard Pzena's REGN Position: Q3 2026 in Review

Richard Pzena opened a new position in Regeneron Pharmaceuticals (REGN) in Q3 2026: 409 shares worth $310K. The stake represents ﹤0.01% of the portfolio and ranks #152 among its holdings. This is a return to the name: Richard Pzena previously reported a position in REGN as recently as Q3 2022.

Richard Pzena first reported a position in REGN in Q1 2021 and has held it in 8 quarters since. The position peaked at $661K in Q2 2022. 1,433 funds tracked by Wall St. Rank hold REGN as of Q3 2026.

  • Richard Pzena held 409 shares of Regeneron Pharmaceuticals worth $310K as of Q3 2026.
  • Regeneron Pharmaceuticals was a new Richard Pzena position in Q3 2026.
  • Regeneron Pharmaceuticals made up ﹤0.01% of Richard Pzena's portfolio in Q3 2026, its #152 holding.
  • Richard Pzena first reported a position in Regeneron Pharmaceuticals in Q1 2021 and has held it in 8 quarters since.
  • Richard Pzena's Regeneron Pharmaceuticals position peaked at $661K in Q2 2022.
  • 1,433 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2026.

Based on Pzena Investment Management's 13F filing for Q3 2026, filed 30 Oct 2026.